Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

47.91
-2.3200-4.62%
Pre-market: 47.80-0.1100-0.23%07:49 EDT
Volume:7.17M
Turnover:345.99M
Market Cap:5.90B
PE:12.75
High:50.25
Open:50.25
Low:47.50
Close:50.23
Loading ...
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 26, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 25, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2023

Correspondence

Form CORRESP - Correspondence
Jun 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
Apr 18, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 23, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals